title: Evidence for multifactorial origin of diabetes-induced embryopathies.
abstract: Serum factors characteristically altered in the diabetic state, e.g., glucose, ketone bodies (beta-hydroxybutyrate), and somatomedin inhibitors, induce dysmorphogenesis with or without growth retardation in rodent embryos in whole-embryo culture. Furthermore, serum from diabetic animals, which contains combinations of altered factors, is teratogenic, thereby implying that the diabetic embryopathy is of a multifactorial origin. However, a detailed investigation with various combinations of factors at known concentrations to test this hypothesis has not been conducted. Therefore, we employed combinations of hyperglycemia (300 and 600 mg/dl; 16.6 and 33.3 mM), hyperketonemia (8 and 16 mM D-beta-hydroxybutyrate), and an 800- to 1000-Mr somatomedin-inhibitor serum fraction (at an amount equal to that found in 0.05 and 0.1 ml of serum from a diabetic rat per deciliter culture medium), which represented doses with low teratogenic potential, to determine if interactions of the factors could occur that would increase the risk of malformations in mouse embryos exposed in whole-embryo culture during gastrulation and neurulation. The results demonstrate that glucose and D-beta-hydroxybutyrate can act synergistically to produce growth retardation and additively to induce malformations. The addition of the somatomedin inhibitor exacerbates the induction of malformations produced by the ketone body and glucose. Thus, the origin of the diabetic embryopathy may be multifactorial, involving several altered maternal factors.
authors.affiliation: Department of Cell Biology and Anatomy, School of Medicine, University of North Carolina, Chapel Hill 27599.
authors.forename: T W
authors.initials: TW
authors.lastname: Sadler
authors.forename: E S
authors.initials: ES
authors.lastname: Hunter
authors.forename: R E
authors.initials: RE
authors.lastname: Wynn
authors.forename: L S
authors.initials: LS
authors.lastname: Phillips
mesh_terms: D020155:3-Hydroxybutyric Acid; D000818:Animals; D000013:Congenital Abnormalities / Q000209:etiology*; D003921:Diabetes Mellitus, Experimental / Q000097:blood; D005260:Female; D005317:Fetal Growth Retardation / Q000209:etiology; D006885:Hydroxybutyrates / Q000633:toxicity; D006943:Hyperglycemia / Q000150:complications; D051379:Mice; D008813:Mice, Inbred ICR; D009436:Neural Tube Defects / Q000209:etiology; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000150:complications*; D011506:Proteins / Q000032:analysis
chemical_list: D006885:Hydroxybutyrates; D011506:Proteins; D020155:3-Hydroxybutyric Acid